Franklin, IN, United States of America

Lisa Selsam Beavers


 

Average Co-Inventor Count = 6.2

ph-index = 4

Forward Citations = 111(Granted Patents)


Location History:

  • Trafalgar, IN (US) (1990 - 1996)
  • Franklin, IN (US) (2008 - 2012)

Company Filing History:


Years Active: 1990-2012

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Lisa Selsam Beavers

Introduction

Lisa Selsam Beavers, an accomplished inventor based in Franklin, Indiana, has made significant strides in the field of pharmaceuticals. With a total of 10 patents to her name, her work focuses on novel compounds with therapeutic uses relating to histamine H3 receptors. Her contributions not only advance scientific knowledge but also hold potential for treating various medical conditions.

Latest Patents

Her latest patents include groundbreaking inventions concerning histamine H3 receptor agents. These inventions disclose novel compounds of Formula (I) or pharmaceutically acceptable salts that possess histamine H3 receptor antagonist or inverse agonist activity. The patents also describe methods and intermediates for preparing these compounds, alongside pharmaceutical compositions aimed at treating conditions such as obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases.

Career Highlights

Lisa Selsam Beavers is affiliated with Eli Lilly and Company, a leading pharmaceutical firm known for its innovative approach to healthcare. Throughout her career, she has been dedicated to research and development, aimed at discovering new treatments that can improve patient outcomes.

Collaborations

In her professional journey, Lisa has had the opportunity to collaborate with notable colleagues, including Robert Alan Gadski and Richard Todd Pickard. These collaborations have fostered an environment of creativity and innovation, essential for advancing their collective mission in drug development.

Conclusion

Lisa Selsam Beavers stands out as a prominent figure in the field of pharmaceutical innovations. Her patents reflect a deep commitment to research and the potential to improve health outcomes for individuals affected by various health conditions. As she continues to work with Eli Lilly and Company, her contributions will undoubtedly influence the future of medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…